Missed opportunities for the secondary prevention of cardiovascular disease in Canada

This publication has 52 references indexed in Scilit:

• Angiotensin-Converting Enzyme Inhibitors and Calcium Channel Blockers for Coronary Heart Disease and Stroke Prevention
  Hypertension, 2005
• Practical considerations of β-blockade in the management of the post–myocardial infarction patient
  American Heart Journal, 2005
• Angiotensin-Converting–Enzyme Inhibition in Stable Coronary Artery Disease
  New England Journal of Medicine, 2004
• Blood Pressure Reduction and Secondary Prevention of Stroke and Other Vascular Events
  Stroke, 2003
• Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
  JAMA, 2002
• ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins
  Stroke, 2002
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
  Published by Elsevier ,2002
• Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
  BMJ, 2002
• Effects of quinapril on clinical outcome after coronary artery bypass grafting (the QUO VADIS study)
  The American Journal of Cardiology, 2001
• A Clinical Trial of the Angiotensin-Converting–Enzyme Inhibitor Trandolapril in Patients with Left Ventricular Dysfunction after Myocardial Infarction
  New England Journal of Medicine, 1995